Stephen Liu: Best Practices for ALK-Positive NSCLC by Jessica Lin at DC Lung24

Stephen Liu shared a post on X:

”Jessica Lin from MGH Thoracic Oncology will discuss advances in targeting ALK in advanced NSCLC at DC Lung24. Learn about the new wave of drugs! Join us Saturday, October 19th in downtown Washington, DC for this IASLC (International Association for the Study of Lung Cancer) endorsed, one-day CME meeting!”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.